Published in J Med Chem on February 01, 1989
Brain vasopressin is an important regulator of maternal behavior independent of dams' trait anxiety. Proc Natl Acad Sci U S A (2008) 1.40
Immunohistochemical localization of V2 vasopressin receptor along the nephron and functional role of luminal V2 receptor in terminal inner medullary collecting ducts. J Clin Invest (1995) 0.94
Interactive effects of neurohypophyseal neuropeptides with receptor antagonists on passive avoidance behavior: mediation by a cerebral neurohypophyseal hormone receptor? Proc Natl Acad Sci U S A (1991) 0.90
Oxytocin receptor couples to the 80 kDa Gh alpha family protein in human myometrium. Biochem J (1996) 0.89
Impairments in the initiation of maternal behavior in oxytocin receptor knockout mice. PLoS One (2014) 0.89
Maternal aggression in rodents: brain oxytocin and vasopressin mediate pup defence. Philos Trans R Soc Lond B Biol Sci (2013) 0.88
Central inhibition by gamma-aminobutyric acid and muscimol of the release of vasopressin and oxytocin by an osmotic stimulus in the rat. Br J Pharmacol (1990) 0.86
Pharmacologic characterization of the oxytocin receptor in human uterine smooth muscle cells. Br J Pharmacol (2000) 0.85
Oxytocin Regulates Stress-Induced Crf Gene Transcription through CREB-Regulated Transcription Coactivator 3. J Neurosci (2015) 0.83
Fluorescent agonists and antagonists for vasopressin/oxytocin G protein-coupled receptors: usefulness in ligand screening assays and receptor studies. Mini Rev Med Chem (2008) 0.83
Blocking oxytocin receptors inhibits vaginal marking to male odors in female Syrian hamsters. Physiol Behav (2010) 0.83
Effects of vasopressin and angiotensin II on neurones in the rat dorsal motor nucleus of the vagus, in vitro. J Physiol (1992) 0.82
Phospholipase C-delta1 and oxytocin receptor signalling: evidence of its role as an effector. Biochem J (1998) 0.82
Early Life Manipulations of the Nonapeptide System Alter Pair Maintenance Behaviors and Neural Activity in Adult Male Zebra Finches. Front Behav Neurosci (2016) 0.81
Vasopressin-stimulated phosphoinositide hydrolysis in cultured rat inner medullary collecting duct cells is mediated by the oxytocin receptor. J Clin Invest (1991) 0.81
Design, synthesis, and pharmacological characterization of fluorescent peptides for imaging human V1b vasopressin or oxytocin receptors. J Med Chem (2011) 0.80
Developmental effects of vasotocin and nonapeptide receptors on early social attachment and affiliative behavior in the zebra finch. Horm Behav (2015) 0.77
Natural variation in paternal behavior is associated with central estrogen receptor alpha and oxytocin levels. J Comp Physiol A Neuroethol Sens Neural Behav Physiol (2015) 0.77
Axotomy induces the expression of vasopressin receptors in cranial and spinal motor nuclei in the adult rat. Proc Natl Acad Sci U S A (1994) 0.75
Role of the oxytocin system in amygdala subregions in the regulation of social interest in male and female rats. Neuroscience (2016) 0.75
Complete genomic sequence and analysis of the prion protein gene region from three mammalian species. Genome Res (1998) 3.44
Chemical and physical properties of an arabinogalactan-peptide from wheat endosperm. Biochem J (1974) 2.56
Nucleotide sequence and genetic map of the 16-kb vaccinia virus HindIII D fragment. Virology (1986) 2.25
Fluorescence anisotropy applied to biomolecular interactions. Methods Enzymol (1995) 1.84
Snapshot of a large dynamic replicon in a halophilic archaeon: megaplasmid or minichromosome? Genome Res (1998) 1.81
Vaccinia virus gene D8 encodes a virion transmembrane protein. J Virol (1988) 1.78
The fragile X mental retardation protein binds and regulates a novel class of mRNAs containing U rich target sequences. Neuroscience (2003) 1.69
Anaerobic culture on growth efficient bi-layered culture plate in a modified candle jar using a rapid and slow combustion system. Indian J Med Microbiol (2013) 1.67
The assay of milk-ejecting activity in the lactating rat. Br J Pharmacol Chemother (1967) 1.63
Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics. J Neuroendocrinol (2012) 1.63
Properties and the locations of a set of fluorescent probes sensitive to the fluidity gradient of the lipid bilayer. Biochim Biophys Acta (1978) 1.55
Extraction of membrane microviscosity from translational and rotational diffusion coefficients. Biophys J (1982) 1.51
Primary orbital Ewing's sarcoma: report of a case and review of the literature. Eye (Lond) (1999) 1.46
Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis. Mol Pharmacol (1986) 1.43
Assessing prostate cancer growth with citrate measured by intact tissue proton magnetic resonance spectroscopy. Prostate Cancer Prostatic Dis (2012) 1.42
The ring-infected erythrocyte surface antigen of Plasmodium falciparum associates with spectrin in the erythrocyte membrane. Mol Biochem Parasitol (1991) 1.41
Spectral properties of the prototropic forms of fluorescein in aqueous solution. J Fluoresc (1996) 1.35
Design and synthesis of a peptide having chymotrypsin-like esterase activity. Science (1990) 1.33
Changes in 32 p-labelling of platelet phospholipids in response to ADP. Br J Haematol (1972) 1.29
Physicochemical studies on the lactate dehydrogenase of Streptococcus cremoris US3: the effects of modifiers. Biochim Biophys Acta (1971) 1.29
Genetic map of the vaccinia virus HindIII D Fragment. Virology (1987) 1.29
Neurohypophysial principles in rats homozygous and heterozygous for hypothalamic diabetes insipidus (Brattleboro strain). Endocrinology (1965) 1.27
In situ multi-level analysis of viscoelastic deformation mechanisms in tendon collagen. J Struct Biol (2009) 1.25
125I-labelled d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH2(9)]OVT: a selective oxytocin receptor ligand. Eur J Pharmacol (1988) 1.25
A randomised trial comparing 0.02% mitomycin C and limbal conjunctival autograft after excision of primary pterygium. Br J Ophthalmol (2004) 1.20
Tryptophan rotamer distributions in amphipathic peptides at a lipid surface. Biophys J (1999) 1.20
Superinfection exclusion of vaccinia virus in virus-infected cell cultures. Virology (1990) 1.19
The effect of self-association on the interaction of the Escherichia coli regulatory protein TyrR with DNA. J Mol Biol (1996) 1.19
Early brain injury in the SIV-macaque model of AIDS. AIDS (2000) 1.17
Cytosine arabinoside influx and nucleoside transport sites in acute leukemia. J Clin Invest (1982) 1.15
NMR spectroscopy in beta cell engineering and islet transplantation. Ann N Y Acad Sci (2001) 1.14
Blood levels of oxytocin and vasopressin during suckling in the rabbit and the problem of their independent release. J Physiol (1970) 1.13
Human apolipoprotein C-II forms twisted amyloid ribbons and closed loops. Biochemistry (2000) 1.12
The molecular weight and stability of concanavalin A. Biochim Biophys Acta (1972) 1.10
Structural requirements for activation of vasopressin-sensitive adenylate cyclase, hormone binding, and antidiuretic actions: effects of highly potent analogues and competitive inhibitors. Mol Pharmacol (1978) 1.10
Complex between beta-lactoglobulin and kappa-casein. A review. J Dairy Sci (1969) 1.09
Spectral properties of fluorescein in solvent-water mixtures: applications as a probe of hydrogen bonding environments in biological systems. Photochem Photobiol (1998) 1.09
The importance of vasopressin in the development and maintenance of DOC-salt hypertension in the rat. Hypertension (1980) 1.08
Vertical fluctuations of phospholipid acyl chains in bilayers. FEBS Lett (1987) 1.06
Vasopressor receptor antagonist prevents behavioural effects of vasopressin. Nature (1981) 1.06
Binding equations for interacting systems comprising multivalent acceptor and bivalent ligand: application to antigen-antibody systems. J Theor Biol (1979) 1.03
An assessment of the fluidity gradient of the lipid bilayer as determined by a set of n-(9-anthroyloxy) fatty acids (n = 2, 6, 9, 12, 16). J Biol Chem (1979) 1.03
Selective, high-affinity binding of ferric ions by glycine-extended gastrin(17). Biochemistry (2001) 1.02
Thyroxine transport in choroid plexus. J Biol Chem (1987) 1.02
Site-specific tryptophan dynamics in class A amphipathic helical peptides at a phospholipid bilayer interface. Biophys J (2000) 1.02
Comparison of fluorescence energy transfer and quenching methods to establish the position and orientation of components within the transverse plane of the lipid bilayer. Application to the gramicidin A--bilayer interaction. Biochemistry (1979) 1.01
Selective uptake of hematoporphyrin derivative into human cerebral glioma. Neurosurgery (1990) 1.01
Structural changes in the arginine vasopressin molecule that enhance antidiuretic activity and specificity. Endocrinology (1974) 1.01
Neurohypophysial peptides. Design of tissue-specific agonists and antagonists. Mol Cell Endocrinol (1981) 1.01
Interaction of lipoprotein lipase with homogeneous lipid emulsions. J Lipid Res (1997) 1.00
Independent release of oxytocin and vasopressin during parturition in the rabbit. J Physiol (1970) 1.00
The dissociation of proteins by chaotropic salts. J Biol Chem (1973) 0.99
Spinal cord injury: prognosis for ambulation based on quadriceps recovery. Paraplegia (1992) 0.98
Discovery, development, and some uses of vasopressin and oxytocin antagonists. J Lab Clin Med (1989) 0.97
A modified technique of scleral fixated intraocular lenses for aphakic correction. Eye (Lond) (2005) 0.96
Binding of fluoresceinated epidermal growth factor to A431 cell sub-populations studied using a model-independent analysis of flow cytometric fluorescence data. EMBO J (1986) 0.94
Depth-dependent fluorescent quenching of a tryptophan residue located at defined positions on a rigid 21-peptide helix in liposomes. Biochim Biophys Acta (1987) 0.94
Design of potent and selective antagonists of the vasopressor responses to arginine-vasopressin. J Med Chem (1982) 0.94
Expression and analysis of heparin-binding regions of the amyloid precursor protein of Alzheimer's disease. FEBS Lett (1997) 0.94
Protein bisoynthesis in the testis. IV. Isolation and properties of polyribosomes. Biochemistry (1969) 0.94
Third ventricular injection of hypertonic NaCl and natriuresis in cats. Am J Physiol (1974) 0.94
Trifluoroethanol induces the self-association of specific amphipathic peptides. FEBS Lett (1997) 0.94
Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma. J Clin Invest (1985) 0.94
Rotational diffusion of the erythrocyte integral membrane protein band 3: effect of hemichrome binding. Biochemistry (1992) 0.94
Characterization of a uterine-type oxytocin receptor in the rat hippocampus. Proc Natl Acad Sci U S A (1983) 0.94
A microviscosity barrier in the lipid bilayer due to the presence of phospholipids containing unsaturated acyl chains. Biochem Biophys Res Commun (1978) 0.93
Evolution of antidiuretic hormones and their functions. Am J Med (1967) 0.93
Cytosine arabinoside transport by human leukaemic cells. Eur J Cancer Clin Oncol (1983) 0.93
Vasopressin analogs that antagonize antidiuretic responses by rats to the antidiuretic hormone. Science (1981) 0.92
Proteolytic digestion of band 3 at an external site alters the erythrocyte membrane organisation and may facilitate malarial invasion. Mol Biochem Parasitol (1993) 0.92
Renal responses of Australian lungfish to vasotocin, angiotensin II, and NaCl infusion. Am J Physiol (1976) 0.91
Purification and characterization of a galactan-reactive agglutinin from the clam Tridacna maxima (Röding) and a study of its combining site. Biochem J (1978) 0.91
Decreased rotational diffusion of band 3 in Melanesian ovalocytes from Papua, New Guinea. J Membr Biol (1991) 0.91
Design, synthesis and some uses of receptor-specific agonists and antagonists of vasopressin and oxytocin. J Recept Res (1993) 0.91
The use of autologous serum tears in persistent corneal epithelial defects. Eye (Lond) (2004) 0.91
Design of potent antagonists of the vasopressor response to arginine-vasopressin. J Med Chem (1978) 0.91
Reversal of multidrug resistance by surfactants. Br J Cancer (1992) 0.91
Decreased membrane deformability in Melanesian ovalocytes from Papua New Guinea. J Cell Biol (1984) 0.90
The binding properties of dimeric and tetrameric concanavalin A. Binding of ligands to noninteracting macromolecular acceptors. J Biol Chem (1973) 0.90
Design of more potent antagonists of the antidiuretic responses to arginine-vasopressin. J Med Chem (1982) 0.90
Design and synthesis of potent in vivo antagonists of oxytocin. Int J Pept Protein Res (1980) 0.90